Mr. Speaker, I rise today in support of H.R. 3743, Supporting the Foundation for the National Institutes of Health and the Reagan-Udall Foundation for the Food and Drug Administration Act, led by my Energy and Commerce Committee colleagues, Representative Hudson and Representative Eshoo.
Empowering biomedical innovation in the United States is critical to protecting our global competitiveness. We saw how important it was to invest in creating new treatments during the COVID-19 pandemic, and we need to carry that momentum into the future.
H.R. 3743 authorizes increased transfer authorities from the FDA and the NIH to both the Reagan-Udall Foundation and the Foundation for the NIH, respectively.
Allowing FDA and NIH to provide increased funding to these public- private partnerships will give the Reagan-Udall Foundation and the Foundation for the NIH more flexibility to meet the growing research demands and to ultimately accelerate future medical innovations.
I urge my colleagues to support this bill, and I reserve the balance of my time.
BREAK IN TRANSCRIPT